SCHEMBL4024847

SCHEMBL4024847

Nc1nc(-c2ccccn2)ncc1-c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.50
L3MBTL1 Q9Y468 3/20 0.50
ALOX15 P16050 1/20 0.50
TDP1 Q9NUW8 1/20 0.48
RAB9A P51151 6/20 0.47
SMN1; SMN2 Q16637 6/20 0.47
NPC1 O15118 5/20 0.47
TP53 P04637 4/20 0.47
PKM P14618 3/20 0.47
TGFBR1 P36897 1/20 0.46
HPGDS O60760 2/20 0.46
LMNA P02545 3/20 0.45
HPGD P15428 2/20 0.45
ALDH1A1 P00352 2/20 0.45
TSHR P16473 2/20 0.45
MAPT P10636 1/20 0.45
KLF5 Q13887 1/20 0.45
HSD17B10 Q99714 1/20 0.45
CHEK2 O96017 1/20 0.44
CASP3 P42574 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16916721 0.91 SMN1; SMN2 (0.50) KDM4EL3MBTL1ALOX15TDP1RAB9A
SCHEMBL27735106 0.83 FGFR1 (0.49) RAB9ASMN1; SMN2NPC1TP53LMNA
SCHEMBL12397268 0.81 KDM4E (0.48) KDM4EL3MBTL1TDP1RAB9ASMN1; SMN2
SCHEMBL1137587 0.81 SMN1; SMN2 (0.57) KDM4EL3MBTL1TDP1RAB9ASMN1; SMN2
SCHEMBL1137830 0.81 KDM4E (0.48) KDM4EL3MBTL1ALOX15TDP1RAB9A
SCHEMBL16916718 0.78 KDM4E (0.49) KDM4EL3MBTL1ALOX15TDP1RAB9A
SCHEMBL28455254 0.77 L3MBTL1 (0.53) KDM4EL3MBTL1ALOX15TDP1RAB9A
SCHEMBL16876611 0.77 L3MBTL1 (0.53) KDM4EL3MBTL1ALOX15TDP1RAB9A
SCHEMBL24787416 0.76 L3MBTL1 (0.52) KDM4EL3MBTL1ALOX15TDP1RAB9A
SCHEMBL6760896 0.75 KDM4E (0.47) KDM4EL3MBTL1ALOX15TDP1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1504001-B1 2-(2-PYRIDYL)-5-PHENYL-6-AMINOPYRIMIDINE, METHOD AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION AND USE THEREOF FOR COMBATING NOXIOUS FUNGI BASF SE (DE) 2009-04-15 EP claimed
US-7320975-B2 2-(2-pyridyl)-5-phenyl-6-aminopyrimidine, method and intermediate products for the production and use thereof for combating noxious fungi BASF AKTIENGESELLSCHAFT (DE) 2008-01-22 US claimed
US-20050107401-A1 2- (2-pyridyl) -5-phenyl-6-aminopyrimidine, method and intermediate products for the production and use thereof for combating noxious fungi BASF AKTIENGESELLSCHAFT (DE) 2005-05-19 US claimed
EP-1504001-A1 2-(2-PYRIDYL)-5-PHENYL-6-AMINOPYRIMIDINE, METHOD AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION AND USE THEREOF FOR COMBATING NOXIOUS FUNGI BASF Aktiengesellschaft (DE) 2005-02-09 EP claimed
WO-2003070721-A1 2-(2-PYRIDYL)-5-PHENYL-6-AMINOPYRIMIDINE, METHOD AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION AND USE THEREOF FOR COMBATING NOXIOUS FUNGI BASF AKTIENGESELLSCHAFT (DE) 2003-08-28 WO claimed
EP-1737843-B1 INHIBITORS OF AKT ACTIVITY MERCK SHARP & DOHME (US) 2011-02-23 EP disclosed
EP-1504001-B1 2-(2-PYRIDYL)-5-PHENYL-6-AMINOPYRIMIDINE, METHOD AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION AND USE THEREOF FOR COMBATING NOXIOUS FUNGI BASF SE (DE) 2009-04-15 EP disclosed
EP-1504001-B1 2-(2-PYRIDYL)-5-PHENYL-6-AMINOPYRIMIDINE, METHOD AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION AND USE THEREOF FOR COMBATING NOXIOUS FUNGI BASF SE (DE) 2009-04-15 EP disclosed
EP-1504001-B1 2-(2-PYRIDYL)-5-PHENYL-6-AMINOPYRIMIDINE, METHOD AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION AND USE THEREOF FOR COMBATING NOXIOUS FUNGI BASF SE (DE) 2009-04-15 EP disclosed
US-7320975-B2 2-(2-pyridyl)-5-phenyl-6-aminopyrimidine, method and intermediate products for the production and use thereof for combating noxious fungi BASF AKTIENGESELLSCHAFT (DE) 2008-01-22 US disclosed
US-7320975-B2 2-(2-pyridyl)-5-phenyl-6-aminopyrimidine, method and intermediate products for the production and use thereof for combating noxious fungi BASF AKTIENGESELLSCHAFT (DE) 2008-01-22 US disclosed
US-7320975-B2 2-(2-pyridyl)-5-phenyl-6-aminopyrimidine, method and intermediate products for the production and use thereof for combating noxious fungi BASF AKTIENGESELLSCHAFT (DE) 2008-01-22 US disclosed
US-20050107401-A1 2- (2-pyridyl) -5-phenyl-6-aminopyrimidine, method and intermediate products for the production and use thereof for combating noxious fungi BASF AKTIENGESELLSCHAFT (DE) 2005-05-19 US disclosed
US-20050107401-A1 2- (2-pyridyl) -5-phenyl-6-aminopyrimidine, method and intermediate products for the production and use thereof for combating noxious fungi BASF AKTIENGESELLSCHAFT (DE) 2005-05-19 US disclosed
EP-1504001-A1 2-(2-PYRIDYL)-5-PHENYL-6-AMINOPYRIMIDINE, METHOD AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION AND USE THEREOF FOR COMBATING NOXIOUS FUNGI BASF Aktiengesellschaft (DE) 2005-02-09 EP disclosed
EP-1504001-A1 2-(2-PYRIDYL)-5-PHENYL-6-AMINOPYRIMIDINE, METHOD AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION AND USE THEREOF FOR COMBATING NOXIOUS FUNGI BASF Aktiengesellschaft (DE) 2005-02-09 EP disclosed
EP-1504001-A1 2-(2-PYRIDYL)-5-PHENYL-6-AMINOPYRIMIDINE, METHOD AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION AND USE THEREOF FOR COMBATING NOXIOUS FUNGI BASF Aktiengesellschaft (DE) 2005-02-09 EP disclosed
WO-2003070721-A1 2-(2-PYRIDYL)-5-PHENYL-6-AMINOPYRIMIDINE, METHOD AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION AND USE THEREOF FOR COMBATING NOXIOUS FUNGI BASF AKTIENGESELLSCHAFT (DE) 2003-08-28 WO disclosed
WO-2003070721-A1 2-(2-PYRIDYL)-5-PHENYL-6-AMINOPYRIMIDINE, METHOD AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION AND USE THEREOF FOR COMBATING NOXIOUS FUNGI BASF AKTIENGESELLSCHAFT (DE) 2003-08-28 WO disclosed
WO-2003070721-A1 2-(2-PYRIDYL)-5-PHENYL-6-AMINOPYRIMIDINE, METHOD AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION AND USE THEREOF FOR COMBATING NOXIOUS FUNGI BASF AKTIENGESELLSCHAFT (DE) 2003-08-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107401-A1 2- (2-pyridyl) -5-phenyl-6-aminopyrimidine, method and intermediate products for the production and use thereof for combating noxious fungi HAAO, HAO1, DAO KDM4E 2544/4885L3MBTL1 429/4885ALOX15 487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.